Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
OBS Medical - Visensia Mobile
| Project | Early Detection of Patient Deterioration from Wireless Wrist-Worn Device Integrating pulse rate, breathing rate and oxygen saturation |
|---|---|
| Description |
Piloting Visensia Mobile, to improve patient safety and outcomes through the early detection of patient deterioration and instability. Continuous multi-dimensional monitoring in the form of a single index (VSI) of patients status via non-invasive measurement of Heart Rate, SpO2 and derived Respiratory Rate from the PPG waveform. |
| Funding | £ 833,886 |
| Competition | Competitions 1- 4 |
| Competition Date | September 2013 |
| Website | http://www.obsmedical.com/ |
Polyphotonix
| Project | Home based treatment for Diabetic Retinopathy and Age-related Macular Degeneration |
|---|---|
| Description |
The Phase 3 project has been the catalyst for Noctura 400 (non-invasive, home based treatment for Diabetic Retinopathy) evaluation within the NHS. It has also initiated complimentary evaluation for early stage disease intervention in a primary care Optometry setting. Noctura 400 exposure has been increased as a result and as such has stimulated significant adoption interest from both patient groups and eye care professionals. |
| Funding | £ 1,215,132 |
| Competition | Competitions 1- 4 |
| Competition Date | September 2013 |
| Health Innovation Network Partner | Health Innovation North East and North Cumbria |
| Website | http://www.polyphotonix.com/ |
TidalSense
| Project | Tidal Breathing High Resolution Capnography to Quantify Obstructed Airflow in Wheezy Children including children <5years old |
|---|---|
| Description |
TidalSense has patented an innovative fast-response CO2 sensor within a connected, handheld and battery-operated handset (N-Tidal Handset). TidalSense has also developed, and is ready to bring to market N-Tidal Diagnose, software with embedded AI algorithms that can sensitively detect changes in lung physiology consistent with COPD. Class 2a EU MDR regulatory approval for N-Tidal Diagnose is anticipated in calendar Q1/Q2 2025. This project will develop prototype AI-derived asthma diagnostic software to be combined with N-Tidal hardware for children and determine how it could be used in clinical practice. |
| Funding | £ 886,826 |
| Competition | Competition 23 - Child Health |
| Competition Date | August 2023 |
| Categories | Children and Young people |
| Health Innovation Network Partner | Health Innovation East |
| Website | https://tidalsense.com/ |